Literature DB >> 12054761

Domain-swapped structure of a mutant of cyanovirin-N.

Istvan Botos1, Toshiyuki Mori, Laura K Cartner, Michael R Boyd, Alexander Wlodawer.   

Abstract

Cyanovirin-N (CV-N) is a potent 11 kDa HIV-inactivating protein that binds with high affinity to the HIV surface envelope protein gp120. A double mutant P51S/S52P of CV-N was engineered by swapping two critical hinge-region residues Pro51 and Ser52. This mutant has biochemical and biophysical characteristics equivalent to the wild-type CV-N and its structure resembles that of wild-type CV-N. However, the mutant shows a different orientation in the hinge region that connects two domains of the protein. The observation that this double mutant crystallizes under a wide variety of conditions challenges some of the current hypotheses on domain swapping and on the role of hinge-region proline residues in domain orientation. The current structure contributes to the understanding of domain swapping in cyanovirins, permitting rational design of domain-swapped CV-N mutants.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12054761     DOI: 10.1016/S0006-291X(02)00455-2

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Open interface and large quaternary structure movements in 3D domain swapped proteins: insights from molecular dynamics simulations of the C-terminal swapped dimer of ribonuclease A.

Authors:  Antonello Merlino; Marc Antoine Ceruso; Luigi Vitagliano; Lelio Mazzarella
Journal:  Biophys J       Date:  2004-12-13       Impact factor: 4.033

2.  NMR solution structure of a cyanovirin homolog from wheat head blight fungus.

Authors:  Elena Matei; John M Louis; JunGoo Jee; Angela M Gronenborn
Journal:  Proteins       Date:  2011-03-01

3.  Anti-HIV activity of defective cyanovirin-N mutants is restored by dimerization.

Authors:  Elena Matei; Andrew Zheng; William Furey; Jeremy Rose; Christopher Aiken; Angela M Gronenborn
Journal:  J Biol Chem       Date:  2010-02-10       Impact factor: 5.157

4.  Multivalent interactions with gp120 are required for the anti-HIV activity of Cyanovirin.

Authors:  Yinan Liu; Jacob R Carroll; Lindsey A Holt; James McMahon; Barbara Giomarelli; Giovanna Ghirlanda
Journal:  Biopolymers       Date:  2009       Impact factor: 2.505

5.  Solution and crystal molecular dynamics simulation study of m4-cyanovirin-N mutants complexed with di-mannose.

Authors:  Ivan I Vorontsov; Osamu Miyashita
Journal:  Biophys J       Date:  2009-11-04       Impact factor: 4.033

6.  Solution and crystal structures of a sugar binding site mutant of cyanovirin-N: no evidence of domain swapping.

Authors:  Elena Matei; William Furey; Angela M Gronenborn
Journal:  Structure       Date:  2008-08-06       Impact factor: 5.006

7.  A Designed "Nested" Dimer of Cyanovirin-N Increases Antiviral Activity.

Authors:  Brian W Woodrum; Jason Maxwell; Denysia M Allen; Jennifer Wilson; Lauren R H Krumpe; Andrey A Bobkov; R Blake Hill; Karen V Kibler; Barry R O'Keefe; Giovanna Ghirlanda
Journal:  Viruses       Date:  2016-06-06       Impact factor: 5.048

8.  Linker-extended native cyanovirin-N facilitates PEGylation and potently inhibits HIV-1 by targeting the glycan ligand.

Authors:  Jia Chen; Dane Huang; Wei Chen; Chaowan Guo; Bo Wei; Chongchao Wu; Zhou Peng; Jun Fan; Zhibo Hou; Yongsheng Fang; Yifei Wang; Kaio Kitazato; Guoying Yu; Chunbin Zou; Chuiwen Qian; Sheng Xiong
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.